MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group - Top-Institutions - MDSpire

MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group

  • By

  • Gülin Öz

  • Sirio Cocozza

  • Thiago J. R. Rezende

  • Pierre-Gilles Henry

  • Jennifer Faber

  • Ian H. Harding

  • June 3, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    Ataxia Global Initiative
    Ataxia Global Initiative

    N/A, N/A

    Key Differentiators

    • Ataxia Research

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Multiple Sclerosis

  • #3

    GSTT Electronic Record Research Interface
    GSTT Electronic Record Research Interface

    London, England

    Key Differentiators

    • Clinical Research

Original Source(s)

MRI end-points for clinical trials in ataxias: recommendations from the Ataxia Global Initiative MRI Biomarkers Working Group

  • by Gülin Öz, Sirio Cocozza, Thiago J. R. Rezende, Pierre-Gilles Henry, Jennifer Faber, Ian H. Harding

  • June 3, 2026

Related Content

COG5-congenital disorder of glycosylation diagnosed by whole genome sequencing in siblings with unexplained optic atrophy, macular atrophy, and developmental delay: case report

Risk factors for refractory BPPV: subtype-dependent association of serum 25-hydroxyvitamin D

Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical